Genflow Biosciences plc

Research Genflow Biosciences plc (GENF) on Bullrun: market cap GBX 12.46M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerGENF
• ExchangeLSE
• CountryUnited Kingdom
• SectorHealthcare
• IndustryBiotechnology
• CurrencyGBX
• Market capGBX 12.46M
• Financial periodFY2024
• Net income-GBP 1.59M
• Free cash flow-GBP 1.08M

Valuation Snapshot

latest market cap is GBX 12.46M.

About Genflow Biosciences plc

Genflow Biosciences plc, together with its subsidiaries, engages in the research and development of gene therapy targeting the upstream biology of aging in the United Kingdom and Belgium. The company operates as a pre-clinical biotechnology company that focuses on developing biological interventions aimed at tackling the effects of aging, slowing, and halting the aging process, as well as reducing the incidence of age-related diseases.

Frequently asked questions

What is Genflow Biosciences plc's market cap?

Genflow Biosciences plc's market capitalization is GBX 12.46M.

What does Genflow Biosciences plc do?

Genflow Biosciences plc, together with its subsidiaries, engages in the research and development of gene therapy targeting the upstream biology of aging in the United Kingdom and Belgium.